Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Browse Other Projects on Experiment
Related Projects
Crowdcuring the Blues: People, Technology and Research Against Depression
Depression is not a choice, but we can choose to do something about it. Depression is a single label used...
Improving Collaborations for Neglected Tropical Diseases
Neglected tropical diseases (NTDs) infect over a billion of the poorest people in the world, yet only a...
Can we find a low cost solution to store temperature sensitive enzymes in research?
Temperature-sensitive reagents are common in biology labs, and often need to be stored in expensive ultra...